Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis

Blockade of interleukin-5 with reslizumab appears to have significant oral corticosteroid sparing effects in patients with eosinophilic granulomatosis with polyangiitis and severe eosinophilic asthma http://bit.ly/2D2yYSK

Detalles Bibliográficos
Autores principales: Kent, Brian D., d'Ancona, Grainne, Fernandes, Mariana, Green, Linda, Roxas, Cris, Thomson, Louise, Nanzer, Alexandra M., Kavanagh, Joanne, Agarwal, Sangita, Jackson, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970182/
https://www.ncbi.nlm.nih.gov/pubmed/31984211
http://dx.doi.org/10.1183/23120541.00311-2019
Descripción
Sumario:Blockade of interleukin-5 with reslizumab appears to have significant oral corticosteroid sparing effects in patients with eosinophilic granulomatosis with polyangiitis and severe eosinophilic asthma http://bit.ly/2D2yYSK

Ejemplares similares